company background image
SYK logo

Stryker NYSE:SYK Voorraadrapport

Laatste prijs

US$369.02

Marktkapitalisatie

US$141.0b

7D

1.5%

1Y

34.3%

Bijgewerkt

06 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Stryker Corporation

NYSE:SYK Voorraadrapport

Marktkapitalisatie: US$141.0b

SYK Overzicht aandelen

Stryker Corporation is actief als medisch technologiebedrijf.

Over het bedrijf

Beloningen

De winst zal naar verwachting met 11.23% per jaar groeien
De winst groeide het afgelopen jaar met 38.9%

Risicoanalyse

Heeft een hoog schuldenniveau

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Continued MedSurg And Neurotechnology Innovation Drives Exciting Growth And Revenue Momentum

Key Takeaways Ongoing international expansion and strategic acquisitions are The analysts have a consensus price target of $390.28 for Stryker based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $420.0, and the most bearish reporting a price target of just $276.0. In order for you to agree with the analyst's consensus, you'd need to believe that by 2027, revenues will be $27.8 billion, earnings will come to $4.9 billion, and it would be trading on a PE ratio of 36.5x, assuming you use a discount rate of 6.5%.
View narrative
US$390.28
FV
5.4% undervalued intrinsic discount
8.14%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Updated narrative
TO
Tokyo
Community Contributor

Investing in Stryker (SYK) should be an easy ride

Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.
View narrative
US$323.52
FV
14.1% overvalued intrinsic discount
6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 months ago author updated this narrative

Stryker Corporation Concurrenten

Boston Scientific

NYSE:BSX

US$126.1b

Intuitive Surgical

NasdaqGS:ISRG

US$183.5b

Medtronic

NYSE:MDT

US$115.0b

Abbott Laboratories

NYSE:ABT

US$204.2b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Stryker
Historische aandelenkoersen
Huidige aandelenkoersUS$369.02
52 Week HoogtepuntUS$376.04
52 Week LaagUS$266.93
Bèta0.92
11 maand verandering6.92%
3 maanden verandering13.20%
1 Jaar Verandering34.30%
33 jaar verandering36.14%
5 jaar verandering82.93%
Verandering sinds IPO68,026.73%

Recent nieuws en updates

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Oct 10
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Recent updates

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Oct 10
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Sep 29
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Sep 18
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01
We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21
Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11
Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16
The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25
Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14
Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02
Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26
Stryker's (NYSE:SYK) Dividend Will Be $0.80

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14
Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21
At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24
Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02
Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10
Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19
Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26
Is Stryker (NYSE:SYK) A Risky Investment?

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06
Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Rendement voor aandeelhouders

SYKUS Medical EquipmentUS Markt
7D1.5%1.1%2.3%
1Y34.3%29.2%35.1%

Rendement versus industrie: SYK overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement 29.2 % opleverde.

Rendement versus markt: SYK kwam overeen met de US markt, die het afgelopen jaar een rendement opleverde van 35.1 %.

Prijsvolatiliteit

Is SYK's price volatile compared to industry and market?
SYK volatility
SYK Average Weekly Movement2.3%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.2%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: SYK heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van SYK is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
194152,000Kevin Lobowww.stryker.com

Stryker Corporation is een medisch-technologisch bedrijf. Het bedrijf is actief in twee segmenten, MedSurg and Neurotechnology en Orthopaedics and Spine. Het segment Orthopedie en wervelkolom levert implantaten voor gebruik bij totale gewrichtsvervangingen, zoals heup-, knie- en schouderprothesen, en trauma- en extremiteitenchirurgie.

Stryker Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Stryker zich tot de beurswaarde?
SYK fundamentele statistieken
MarktkapitalisatieUS$141.00b
Inkomsten(TTM)US$3.59b
Inkomsten(TTM)US$21.97b

39.2x

Koers/Winstverhouding

6.4x

P/S-verhouding

Is SYK overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SYK resultatenrekening (TTM)
InkomstenUS$21.97b
Kosten van inkomstenUS$7.92b
BrutowinstUS$14.06b
Overige uitgavenUS$10.47b
InkomstenUS$3.59b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)9.42
Brutomarge63.97%
Nettowinstmarge16.34%
Schuld/Eigen Vermogen Verhouding76.8%

Hoe presteerde SYK op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.9%

Huidig dividendrendement

34%

Uitbetalingsratio